Use of milrinone to treat cardiac dysfunction in infants with pulmonary hypertension secondary to congenital diaphragmatic hernia: A review of six patients

Neonatology

Volumn 102, Issue 2, 2012, Pages 130-136

  Patel, Neil ^a  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Congenital diaphragmatic hernia; Milrinone; Newborn infants; Phosphodiesterase 3 inhibitor; Pulmonary hypertension; Tissue Doppler imaging

Indexed keywords

DOBUTAMINE; FENTANYL; MIDAZOLAM; MILRINONE; MORPHINE; NITRIC OXIDE; PROSTAGLANDIN E1; SILDENAFIL;

BLOOD PRESSURE; CLINICAL ARTICLE; CONGENITAL DIAPHRAGM HERNIA; CONTINUOUS INFUSION; DIASTOLE; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; ECHOCARDIOGRAPHY; FEMALE; HEART DISEASE; HEART FUNCTION; HEART RIGHT VENTRICLE; HEART VENTRICLE FUNCTION; HEART VENTRICLE SEPTUM; HIGH FREQUENCY VENTILATION; HUMAN; INFANT; LUNG ARTERY PRESSURE; MALE; PATENT DUCTUS ARTERIOSUS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RETROSPECTIVE STUDY; REVIEW; SYSTOLE; TISSUE DOPPLER IMAGING; TISSUE OXYGENATION;

ANTIHYPERTENSIVE AGENTS; ARTERIAL PRESSURE; CARDIOTONIC AGENTS; DIASTOLE; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HERNIA, DIAPHRAGMATIC; HUMANS; HYPERTENSION, PULMONARY; INFANT, NEWBORN; MALE; MILRINONE; PHOSPHODIESTERASE 3 INHIBITORS; PULMONARY ARTERY; RECOVERY OF FUNCTION; RETROSPECTIVE STUDIES; SYSTOLE; TIME FACTORS; TREATMENT OUTCOME; VASODILATOR AGENTS; VENTRICULAR DYSFUNCTION, RIGHT; VENTRICULAR FUNCTION, RIGHT; VICTORIA;

EID: 84862260285     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000339108     Document Type: Review

References (25)

1. Sehgal A, Athikarisamy SE, Adamopoulos M: Global myocardial function is compromised in infants with pulmonary hypertension. Acta Paediatrica 2012; 101: 410-413.
2. Patel N, Mills JF, Cheung MM: Assessment of right ventricular function using tissue Doppler imaging in infants with pulmonary hypertension. Neonatology 2009; 96: 193- 199, discussion 200-202.
3. Chen EP, Craig DM, Bittner HB, Davis RD, Van Trigt P: Pharmacological strategies for improving diastolic dysfunction in the setting of chronic pulmonary hypertension. Circulation 1998; 97: 1606-1612.
4. McNamara PJ, Laique F, Muang-In S, Whyte HE: Milrinone improves oxygenation in neonates with severe persistent pulmonary hypertension of the newborn. J Crit Care 2006; 21: 217-222.
5. Thebaud B, Tibboel D: Pulmonary hypertension associated with congenital diaphragmatic hernia. Cardiol Young 2009; 19(suppl 1):49-53.
6. Skinner JR, Boys RJ, Hunter S, Hey EN: Noninvasive assessment of pulmonary arterial pressure in healthy neonates. Arch Dis Child 1991; 66: 386-390.
7. Dillon PW, Cilley RE, Mauger D, Zachary C, Meier A: The relationship of pulmonary artery pressure and survival in congenital diaphragmatic hernia. J Pediatr Surg 2004; 39: 307-312, discussion 312.
8. Yamataka T, Puri P: Pulmonary artery structural changes in pulmonary hypertension complicating congenital diaphragmatic hernia. J Pediatr Surg 1997; 32: 387-390.
9. Chin KM, Kim NH, Rubin LJ: The right ventricle in pulmonary hypertension. Coron Artery Dis 2005; 16: 13-18.
10. Kinsella JP, Ivy DD, Abman SH: Pulmonary vasodilator therapy in congenital diaphragmatic hernia: Acute, late, and chronic pulmonary hypertension. Semin Perinatol 2005; 29: 123-128.
11. Noori S, Friedlich P, Wong P, Garingo A, Seri I: Cardiovascular effects of sildenafil in neonates and infants with congenital diaphragmatic hernia and pulmonary hypertension. Neonatology 2007; 91: 92-100.
12. Filan PM, McDougall PN, Shekerdemian LS: Combination pharmacotherapy for severe neonatal pulmonary hypertension. J Paediatr Child Health 2006; 42: 219-220.
13. Hunter L, Richens T, Davis C, Walker G, Simpson JH: Sildenafil use in congenital diaphragmatic hernia. Arch Dis Child Fetal Neonatal Ed. 2009; 94:F467.
14. Mohseni-Bod H, Bohn D: Pulmonary hypertension in congenital diaphragmatic hernia. Semin Pediatr Surg 2007; 16: 126-133.
15. Chen EP, Bittner HB, Davis RD Jr, Van Trigt P 3rd: Milrinone improves pulmonary hemodynamics and right ventricular function in chronic pulmonary hypertension. Ann Thorac Surg 1997; 63: 814-821.
16. Binah O, Sodowick B, Vulliemoz Y, Danilo P Jr, Rosen M: The inotropic effects of amrinone and milrinone on neonatal and young canine cardiac muscle. Circulation 1986; 73:III46-III51.
17. Paradisis M, Evans N, Kluckow M, Osborn D: Randomized trial of milrinone versus placebo for prevention of low systemic blood flow in very preterm infants. J Pediatr 2009; 154: 189-195.
18. Hoffman TM, Wernovsky G, Atz AM, Kulik TJ, Nelson DP, Chang AC, et al: Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation 2003; 107: 996-1002.
19. Bassler D, Choong K, McNamara P, Kirpalani H: Neonatal persistent pulmonary hypertension treated with milrinone: four case reports. Biol Neonate 2006; 89: 1-5.
20. Nikitin NP, Witte KK: Application of tissue Doppler imaging in cardiology. Cardiology 2004; 101: 170-184.
21. Mori K, Nakagawa R, Nii M, Edagawa T, Takehara Y, Inoue M, et al: Pulsed wave Doppler tissue echocardiography assessment of the long axis function of the right and left ventricles during the early neonatal period. Heart 2004; 90: 175-180.
22. Boucek RJ Jr, Martinez R: Echocardiographic determination of right ventricular function. Cardiol Young 2005; 15(suppl 1):48-50.
23. Paradisis M, Evans N, Kluckow M, Osborn D, McLachlan AJ: Pilot study of milrinone for low systemic blood flow in very preterm infants. J Pediatr 2006; 148: 306-313.
24. Chang AC, Atz AM, Wernovsky G, Burke RP, Wessel DL: Milrinone: systemic and pulmonary hemodynamic effects in neonates after cardiac surgery. Crit Care Med 1995; 23: 1907-1914.
25. Bassler D, Kreutzer K, McNamara P, Kirpalani H: Milrinone for persistent pulmonary hypertension of the newborn. Cochrane Database Syst Rev 2010; 11:CD007802.